XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,293,503 | -11.3% | 67,140 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $2,584,890 | +7.6% | 67,140 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $2,402,940 | -9.2% | 67,140 | 0.0% | 0.00% | -25.0% |
Q4 2022 | $2,647,330 | +9.2% | 67,140 | 0.0% | 0.00% | +33.3% |
Q3 2022 | $2,423,754 | – | 67,140 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |